134 related articles for article (PubMed ID: 27329196)
21. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
22. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
[TBL] [Abstract][Full Text] [Related]
23. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
[TBL] [Abstract][Full Text] [Related]
24. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Keys HM; Roberts JA; Brunetto VL; Zaino RJ; Spirtos NM; Bloss JD; Pearlman A; Maiman MA; Bell JG;
Gynecol Oncol; 2004 Mar; 92(3):744-51. PubMed ID: 14984936
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
[TBL] [Abstract][Full Text] [Related]
26. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
McCloskey SA; Tchabo NE; Malhotra HK; Odunsi K; Rodabaugh K; Singhal P; Lele S; Jaggernauth W
Gynecol Oncol; 2010 Mar; 116(3):404-7. PubMed ID: 19944453
[TBL] [Abstract][Full Text] [Related]
29. Predictors of recurrence in surgical stage II endometrial adenocarcinoma.
Feltmate CM; Duska LR; Chang Y; Flynn CE; Nikrui N; Kiggundu E; Goodman A; Fuller AF; McIntyre JF
Gynecol Oncol; 1999 Jun; 73(3):407-11. PubMed ID: 10366468
[TBL] [Abstract][Full Text] [Related]
30. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
[TBL] [Abstract][Full Text] [Related]
31. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
Rasool N; Fader AN; Seamon L; Neubauer NL; Shahin FA; Alexander HA; Moore K; Moxley K; Secord AA; Kunos C; Rose PG; O'Malley DM
Gynecol Oncol; 2010 Jan; 116(1):10-4. PubMed ID: 19875158
[TBL] [Abstract][Full Text] [Related]
32. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: a retrospective multi-institutional analysis of 248 patients in Japan.
Eto T; Saito T; Kasamatsu T; Nakanishi T; Yokota H; Satoh T; Nogawa T; Yoshikawa H; Kamura T; Konishi I
Gynecol Oncol; 2012 Nov; 127(2):338-44. PubMed ID: 22910693
[TBL] [Abstract][Full Text] [Related]
34. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
Creutzberg CL; van Putten WL; Wárlám-Rodenhuis CC; van den Bergh AC; de Winter KA; Koper PC; Lybeert ML; Slot A; Lutgens LC; Stenfert Kroese MC; Beerman H; van Lent M;
J Clin Oncol; 2004 Apr; 22(7):1234-41. PubMed ID: 15051771
[TBL] [Abstract][Full Text] [Related]
35. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
Sorbe B; Söderström K
Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors related to recurrent endometrial carcinoma following initial surgery.
Vavra N; Denison U; Kucera H; Barrada M; Kurz C; Salzer H; Sevelda P
Acta Obstet Gynecol Scand; 1993 Apr; 72(3):205-9. PubMed ID: 8385857
[TBL] [Abstract][Full Text] [Related]
37. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
[TBL] [Abstract][Full Text] [Related]
38. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
39. Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria.
Kong TW; Chang SJ; Paek J; Lee Y; Chun M; Ryu HS
J Gynecol Oncol; 2015 Jan; 26(1):32-9. PubMed ID: 25376915
[TBL] [Abstract][Full Text] [Related]
40. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
